Search Results

Metallic Stents Coated With Bioabsorbable Polymers

An overview of polymer technology as a drug-carrier mechanism.

By Wei Fan; Dave M. Johnson, Phd; and Marc D. Feldman, MD, FACC

Next-Generation DES Technology

By Ted E. Feldman, MD, FSCAI - Chief Medical Editor

An Interview With Rajesh M. Dave, MD

A forerunner in research initiatives, Dr. Dave discusses the COURAGE trial, the C3 Conference, and his experience at one of the largest-volume interventional practices in the US.

By Rajesh M. Dave, MD

Current Issues in DES Care

Cardiac Interventions Today engages Rajesh M. Dave, MD, FACC, FSCAI, and Samin K. Sharma, MD, in a discussion about DES safety concerns, patient management, off-label use, and the impact of media coverage.

By Rajesh M. Dave, MD, FACC, FSCAI, and Samin K. Sharma, MD

Aortic Valvuloplasty

The state of the art and an introduction to percutaneous aortic valve technology.

By Rajesh M. Dave, MD, FACC, FSCAI

Drug-Eluting Stents in Coronary CTOs

Recommendations for treating patients with CTOs using new DES technology.

By Rajesh M. Dave, MD, FACC, FSCAI

The Delineation of a Global Vascular Profile

The coexistence of AAA, PAD, and CVD in patients with CAD.

By Carlo A. Dall'Olmo, MD; Allan L. Ippolito, MD; John M. McIlduff, MD; Wayne K. Kinning, MD; Gregory J. Fortin, MD; Scott A. Garner, MD; Robert Molnar, MD; Russell Becker, DO; David B. Wilson, MD; Brenda S. Buckle, ANP, BC; Joanne E. Drago, LPN, RVT, FSVU; and Ann M. Inskeep, RVT

The Two Sides of Vascular Access and Closure

Part 1: Debating the pros and cons of manual compression versus vascular closure devices.

By Zoltan G. Turi, MD

An Interview With Quinn Capers IV, MD, FACC

Dr. Capers discusses the importance of diversity in the physician workforce, how to recognize and counteract unconscious bias, how he led the change at Ohio State to a radial-first cath lab, and more.

Angiographic Characterization of Lesion Morphology

Are the AHA/ACC and SCAI lesion classifications still useful?

By Lloyd W. Klein, MD, and Ronald J. Krone, MD

Examining Device-Driven Therapies for Interventional Heart Failure

By Ulrich Jorde, MD, and Nils Johnson, MD

Diagnosing Gray Zone Coronary Physiology

Moderator: William F. Fearon, MD
Panel: Morton J. Kern, MD, MSCAI, FAHA, FACC; Nils P. Johnson, MD, MS; and John McBarron Hodgson, MD, MSCAI

Patent Foramen Ovale Closure: What Are the Indications?

A summary of lessons learned from positive randomized trial data.

By Mohammad K. Mojadidi, MD; Muhammad O. Zaman, MD; Islam Y. Elgendy, MD, FACP, FESC; Ahmed N. Mahmoud, MD; and Jonathan M. Tobis, MD, FACC, MSCAI

Multivessel Stenting in the Current DES Era

A case report and discussion.

By Andreas Wali, MD, FACC, FSCAI

Patent Foramen Ovale Closure for Cryptogenic Stroke

Developing a treatment strategy guided by clinical data.

By HoHai Van, MD, and Jonathan Tobis, MD

The Spectrum of Devices for Percutaneous Left Atrial Appendage Occlusion

A look at current and emerging nonpharmacologic stroke prevention therapies.

By Lluis Asmarats, MD; and Josep Rodés-Cabau, MD

Poststenting Physiology

The “corroborative standard” of successful PCI.

By Bobby Ghosh, MD; Abdul Hakeem, MD; and Barry Uretsky, MD

Angiography-Based FFR: Reevaluating the Role of the Pressure Wire

Reviewing the nuances of coronary angiography–based FFR and results of initial validation studies.

By Kaneshka Masdjedi, MD, and Joost Daemen, MD, PhD

Think Differently to Innovate Cardiovascular Care

Expand innovation and creativity at your organization.

By Taylr Jesinger, MHA